These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 10933194

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Dual agent chemoprotection by retroviral co-expression of either MDR1 or MRP1 with the P140K mutant of O6-methylguanine-DNA-methyl transferase.
    Southgate TD, Garside E, Margison GP, Fairbairn LJ.
    J Gene Med; 2006 Aug; 8(8):972-9. PubMed ID: 16733832
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Direct reversal of DNA damage by mutant methyltransferase protein protects mice against dose-intensified chemotherapy and leads to in vivo selection of hematopoietic stem cells.
    Ragg S, Xu-Welliver M, Bailey J, D'Souza M, Cooper R, Chandra S, Seshadri R, Pegg AE, Williams DA.
    Cancer Res; 2000 Sep 15; 60(18):5187-95. PubMed ID: 11016647
    [Abstract] [Full Text] [Related]

  • 6. A novel dual function retrovirus expressing multidrug resistance 1 and O6-alkylguanine-DNA-alkyltransferase for engineering resistance of haemopoietic progenitor cells to multiple chemotherapeutic agents.
    Jelinek J, Rafferty JA, Cmejla R, Hildinger M, Chinnasamy D, Lashford LS, Ostertag W, Margison GP, Dexter TM, Fairbairn LJ, Baum C.
    Gene Ther; 1999 Aug 15; 6(8):1489-93. PubMed ID: 10467374
    [Abstract] [Full Text] [Related]

  • 7. Retroviral transduction and expression of the human alkyltransferase cDNA provides nitrosourea resistance to hematopoietic cells.
    Allay JA, Dumenco LL, Koc ON, Liu L, Gerson SL.
    Blood; 1995 Jun 01; 85(11):3342-51. PubMed ID: 7756667
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Chemoprotection of human hematopoietic stem cells by simultaneous lentiviral overexpression of multidrug resistance 1 and O(6)-methylguanine-DNA methyltransferase(P140K).
    Maier P, Spier I, Laufs S, Veldwijk MR, Fruehauf S, Wenz F, Zeller WJ.
    Gene Ther; 2010 Mar 01; 17(3):389-99. PubMed ID: 19865182
    [Abstract] [Full Text] [Related]

  • 10. Chemoprotective gene transfer II: multilineage in vivo protection of haemopoiesis against the effects of an antitumour agent by expression of a mutant human O6-alkylguanine-DNA alkyltransferase.
    Chinnasamy N, Rafferty JA, Hickson I, Lashford LS, Longhurst SJ, Thatcher N, Margison GP, Dexter TM, Fairbairn LJ.
    Gene Ther; 1998 Jun 01; 5(6):842-7. PubMed ID: 9747465
    [Abstract] [Full Text] [Related]

  • 11. Efficient protection of cells from the genotoxicity of nitrosoureas by the retrovirus-mediated transfer of human O6-methylguanine-DNA methyltransferase using bicistronic vectors with human multidrug resistance gene 1.
    Suzuki M, Sugimoto Y, Tsuruo T.
    Mutat Res; 1998 Jun 05; 401(1-2):133-41. PubMed ID: 9639692
    [Abstract] [Full Text] [Related]

  • 12. Expression of retroviral vectors containing the human multidrug resistance 1 cDNA in hematopoietic cells of transplanted mice.
    Sorrentino BP, McDonagh KT, Woods D, Orlic D.
    Blood; 1995 Jul 15; 86(2):491-501. PubMed ID: 7605985
    [Abstract] [Full Text] [Related]

  • 13. Retroviral-mediated gene transduction of human alkyltransferase complementary DNA confers nitrosourea resistance to human hematopoietic progenitors.
    Allay JA, Koç ON, Davis BM, Gerson SL.
    Clin Cancer Res; 1996 Aug 15; 2(8):1353-9. PubMed ID: 9816307
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Protection of hematopoietic cells against combined O6-benzylguanine and chloroethylnitrosourea treatment by mutant forms of O6-methylguanine DNA methyltransferase.
    Williams DA, Maze R, Kurpad C, Pegg A, Erickson LC.
    Bone Marrow Transplant; 2000 May 15; 25 Suppl 2():S105-9. PubMed ID: 10933201
    [Abstract] [Full Text] [Related]

  • 19. Protection of committed murine haemopoietic progenitors against BCNU toxicity does not predict protection of primitive, multipotent spleen colony-forming cells - implications for chemoprotective gene therapy.
    Chinnasamy N, Rafferty J, Lashford L, Chinnasamy D, Margison G, Thatcher N, Dexter T, Fairbairn L.
    Leukemia; 1999 Nov 15; 13(11):1776-83. PubMed ID: 10557052
    [Abstract] [Full Text] [Related]

  • 20. Retrovirus-mediated transfer of the human O6-methylguanine-DNA methyltransferase gene into a murine hematopoietic stem cell line and resistance to the toxic effects of certain alkylating agents.
    Wang G, Weiss C, Sheng P, Bresnick E.
    Biochem Pharmacol; 1996 May 03; 51(9):1221-8. PubMed ID: 8645346
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.